We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock
CDMO

Delisted

CDMO was delisted on the 4th of February, 2025.

Back to rankings

66 hedge funds and large institutions have $13.7M invested in Avid Bioservices, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $12.1M → $13.7M (+$1.55M)

13% less funds holding

Funds holding: 76 → 66 (-10)

40% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 20

77% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 13

Holders
66
Holders Change
-10
Holders Change %
-13.16%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
20
Closed
13
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
-$8K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$427K
2
Deutsche Bank
Deutsche Bank
Germany
+$197K
3
KCM
Kennedy Capital Management
Missouri
+$90.9K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$87.7K
5
Goldman Sachs
Goldman Sachs
New York
+$18K

Top Sellers

Rank Fund Capital Flow
1
PP
Paloma Partners
Connecticut
-$311K
2
LCM
Laurion Capital Management
New York
-$242K
3
Millennium Management
Millennium Management
New York
-$235K
4
CS
Credit Suisse
Switzerland
-$159K
5
PA
Perceptive Advisors
New York
-$76.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.53M -$34.6K -12,881 -1%
KCM
2
Kennedy Capital Management
Missouri
$3.37M +$90.9K +33,823 +3%
BIT
3
BlackRock Institutional Trust
California
$1.75M – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$1.06M +$427K +158,785 +82%
FIM
5
Freedom Investment Management
Connecticut
$634K -$12.6K -4,708 -2%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$468K +$196 +73 +0%
Jacobs Levy Equity Management
7
Jacobs Levy Equity Management
New Jersey
$313K -$45.7K -17,000 -14%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$275K +$87.7K +32,645 +56%
Millennium Management
9
Millennium Management
New York
$221K -$235K -87,334 -54%
Deutsche Bank
10
Deutsche Bank
Germany
$220K +$197K +73,268 New
QI
11
QS Investors
New York
$216K – – –
BA
12
BlackRock Advisors
Delaware
$215K -$4.88K -1,818 -2%
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$206K – – –
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$178K -$3.01K -1,122 -2%
Northern Trust
15
Northern Trust
Illinois
$155K -$132 -49 -0.1%
Goldman Sachs
16
Goldman Sachs
New York
$135K +$18K +6,695 +18%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$90K -$11.7K -4,358 -13%
AQR Capital Management
18
AQR Capital Management
Connecticut
$82K – – –
BBI
19
Baxter Bros Inc
Connecticut
$58K – – –
Ameriprise
20
Ameriprise
Minnesota
$55K -$1.54K -572 -3%
Wells Fargo
21
Wells Fargo
California
$46K – – –
State Street
22
State Street
Massachusetts
$43K – – –
EA
23
Emerald Acquisition
Washington
$32K – – –
GC
24
Guggenheim Capital
Illinois
$26K -$212 -79 -0.9%
VKH
25
Virtu KCG Holdings
New York
$24K -$3.48K -1,294 -14%
1
2 3

CDMO Hedge Fund Activity: Q3 2016 in Review

66 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2016, worth a combined $13.7M — up 13% from $12.1M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CDMO and 3 opened new positions — a net loss of 10 holders — while 20 trimmed existing stakes and 12 added.

The largest buyer was Renaissance Technologies, adding an estimated $427K. The largest seller was Paloma Partners, exiting entirely with an estimated $311K sold.

  • 66 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2016, down from 76 in Q2 2016.
  • Funds reported $13.7M of Avid Bioservices, Inc. Common Stock stock for Q3 2016, up 13% quarter-over-quarter.
  • 3 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2016 and 13 closed out, a net change of -10 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2016 was Renaissance Technologies, an estimated $427K added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q3 2016 was Paloma Partners, an estimated $311K sold.

Based on aggregated 13F filings for Q3 2016.